Novasenta
Pittsburgh, US · Founded 2018
Biotech
Founders & leadership
MK
Matthias KleinzDirector
MM
Mani MohindruExecutive Officer, Director
JC
Jeanne CunicelliDirector
GD
Greg DelgoffeDirector
Reported raises · per SEC filings
Form D private placements▶$15MraisedFeb 2024 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David MooreDirector
- Greg DelgoffeDirector
- Jeanne CunicelliDirector
- Mani MohindruExecutive Officer, Director
- Matthias KleinzDirector
- Offering amount
- $30M
- Amount sold
- $15M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthias KleinzDirector
- Mani MohindruExecutive Officer, Director
- Jeanne CunicelliDirector
- Greg DelgoffeDirector
- Offering amount
- $20M
- Amount sold
- $10M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.